Companies: 10,795·Total market cap: $144.5T
U.S. Physical Therapy, Inc.

U.S. Physical Therapy, Inc.

USPHNYSEHealthcare● Active
$61.30
$-2.15(-3.39%)
Market Cap$932912440
P/E Ratio
52W High$93.5
52W Low$58.19

U.S. Physical Therapy, Inc. (USPH) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

usph · stock forecast · 13 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 13 Wall Street analysts in the past 3 months

SellBuy

Buy

13 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
10
Hold
3
Sell
0
Strong Sell
0
Total: 13 · Buy rate: 76.9%

12-Month Price Target

High

$102

Consensus

$96.00

+56.6% upside

Low

$90.00

Median: $96 · Last Close: $61.30

The U.S. Physical Therapy, Inc. (USPH) analyst consensus is Buy, based on ratings from 13 Wall Street analysts over the past 3 months. The average 12-month USPH price target is $96.00, representing +56.6% upside from the current price of $61.30.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $96 (56.6%)

Consensus Target

$96.00

56.6% upside

High Target

$102

66.4%

Low Target

$90

46.8%

Current Price

$61.30

as of today

Based on analyst price targets, the USPH stock price prediction for the next 12 months ranges from $90 to $102. The consensus USPH price forecast of $96.00 implies 56.6% upside from the current price of $61.30.

Short-Term Price Prediction

Bear

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$61.180.19%

1-day model range: $60.53–$61.83. Peak: $61.83 (-0.19%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$45-26.9%
2028$38-37.7%
2029$35-42.8%
2030$34-45.3%
2031-46.7%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BEARISH

Based on 14 technical indicators

0%7%93%
0Buy
1Neutral
13Sell
RSI (14)37.3Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · USPH · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$62.18SELL
MA 10$62.79SELL
MA 20$62.49SELL
MA 50$69.17SELL
MA 100$75.73SELL
MA 200$78.70SELL
Current $USPH · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$62.24SELL
EMA 10$62.58SELL
EMA 20$63.72SELL
EMA 50$68.09SELL
EMA 100$72.48SELL
EMA 200$76.18SELL
Current $USPH · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Barrington Research2026-05-13
Maintains
OutperformOutperform
Citizens2026-05-08
Maintains
Market OutperformMarket Outperform
Barrington Research2026-02-20
Maintains
OutperformOutperform
Barrington Research2026-01-05
Maintains
OutperformOutperform
JP Morgan2025-11-24
Maintains
OverweightOverweight
Barrington Research2025-10-24
Maintains
OutperformOutperform
Barrington Research2025-08-08
Maintains
OutperformOutperform
Barrington Research2025-07-01
Maintains
OutperformOutperform
JMP Securities2025-04-22
Maintains
Market OutperformMarket Outperform
JP Morgan2025-03-19
Maintains
OverweightOverweight

Wall Street analysts have recently issued updated ratings on U.S. Physical Therapy, Inc. (USPH) stock. Of the recent 57 rating actions, 11 were upgrades and 11 were downgrades. 13 analysts currently cover USPH.

Analyst Recommendation Trends

Buy ratings12↑ +1
Hold ratings00
Sell ratings00

USPH analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 2 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$666M

↓ 20.6% YoY

Revenue Next Year

$779M

↑ 17.0% YoY

EPS This Year

$2.64

EPS Next Year

$2.62

↓ 0.9% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast USPH EPS of $2.64 for the current fiscal year, based on estimates from 6 analysts. The USPH revenue forecast is $666M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The USPH stock forecast is supported by two independent data sources: analyst consensus ratings from 13 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus USPH price target is $96.00 (+56.6% upside), with an analyst consensus of Buy.

The USPH short-term stock prediction for tomorrow is $61.18 (-0.19%). The USPH stock price prediction for 2027 estimates an average of $45. The USPH stock prediction for 2030 projects a range of $31–$37.

U.S. Physical Therapy, Inc. trades on NYSE under the ticker USPH. The USPH stock outlook for 2027 is broadly positive, supported by a Buy consensus among 77% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

USPH forecast · 8 questions

According to 13 Wall Street analysts, the average 12-month USPH price target is $96.00, with a high forecast of $102.00 and a low of $90.00. The median price target is shown in the chart above when available. This implies +56.6% potential upside from the current price of $61.30.

USPH price targetWhat is USPH price targetUSPH analyst price targetUSPH 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.